Product Program year 2020 Source: CMS Open Payments

Sylvant

Drug Hematology

NDC 57894-420-01

Open in the dashboard

General payments

$90,799

361 payments

Research payments

$0

0 payments

Through program year 2020, $90,799 in general payments and $0 in research payments were reported against Sylvant (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $90,799 361

Breakdown

Who paid General payments · program year 2020
  1. EUSA Pharma (US) LLC $90,799 361 payments
Top recipients General payments · program year 2020
  1. Corey Casper Infectious Disease · Seattle, WA $7,650 8% · 4 payments
  2. Girish Venkataraman Anatomic Pathology & Clinical Pathology · Maywood, IL $6,645 7% · 3 payments
  3. Kelty Baker Hematology · Houston, TX $6,449 7% · 8 payments
  4. Sudipto Mukherjee Internal Medicine · Royal Oak, MI $5,970 7% · 3 payments
  5. Amit Mehta Hematology & Oncology · Cary, NC $5,288 6% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $26,506 30% · 163 practitioners
  2. Anatomic Pathology & Clinical Pathology Pathology $11,805 13% · 4 practitioners
  3. Hematology Internal Medicine $11,004 13% · 6 practitioners
  4. Medical Oncology Internal Medicine $10,666 12% · 25 practitioners
  5. Infectious Disease Internal Medicine $7,650 9% · 1 practitioner

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. North Carolina $16,181 18% · 7 recipients
  2. California $10,273 11% · 86 recipients
  3. Texas $8,296 9% · 24 recipients
  4. Washington $7,769 9% · 5 recipients
  5. Illinois $6,769 7% · 7 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

361 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record